AAAAAA
Results:
1-9
|
Results: 9
Authors:
Sikand, VK
Halsey, N
Krause, PJ
Sood, SK
Geller, R
Van Hoecke, C
Buscarino, C
Parenti, D
Citation: Vk. Sikand et al., Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein a vaccine against Lyme disease in healthy children and adolescents: A randomized controlled trial, PEDIATRICS, 108(1), 2001, pp. 123-128
Authors:
Beran, J
Beutels, M
Levie, K
Van Damme, P
Dieussaert, I
Gillet, M
Van Hoecke, C
Tornieporth, N
Citation: J. Beran et al., A single dose, combined vaccine against typhoid fever and hepatitis A: Consistency, immunogenicity and reactogenicity, J TRAVEL M, 7(5), 2000, pp. 246-252
Authors:
Van Hoecke, C
Citation: C. Van Hoecke, Weight-based units reporting of anti-Vi antibody concentrations - Reply, J TRAVEL M, 7(2), 2000, pp. 102-103
Authors:
Beran, J
De Clercq, N
Dieussaert, I
Van Hoecke, C
Citation: J. Beran et al., Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old, CLIN INF D, 31(6), 2000, pp. 1504-1507
Authors:
McCormack, S
Tilzey, A
Carmichael, A
Gotch, F
Kepple, J
Newberry, A
Jones, G
Lister, S
Beddows, S
Cheingsong, R
Rees, A
Babiker, A
Banatvala, J
Bruck, C
Darbyshire, J
Tyrrell, D
Van Hoecke, C
Weber, J
Citation: S. Mccormack et al., A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120(W61D) derived from dual tropic R5X4 HIV-1(ACH320), VACCINE, 18(13), 2000, pp. 1166-1177
Authors:
Schoen, RT
Sikand, VK
Caldwell, MC
Van Hoecke, C
Gillet, M
Buscarino, C
Parenti, DL
Citation: Rt. Schoen et al., Safety and immunogenicity profile of a recombinant outer-surface protein ALyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months, CLIN THER, 22(3), 2000, pp. 315-325
Authors:
Van Hoecke, C
Lebacq, E
Beran, J
Parenti, D
Citation: C. Van Hoecke et al., Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine, CLIN INF D, 28(6), 1999, pp. 1260-1264
Authors:
Feder, HM
Beran, J
Van Hoecke, C
Abraham, B
De Clercq, N
Buscarino, C
Parenti, DL
Citation: Hm. Feder et al., Immunogenicity of a recombinant Borrelia burgdorferi outer surface proteinA vaccine against Lyme disease in children, J PEDIAT, 135(5), 1999, pp. 575-579
Authors:
Lalvani, A
Moris, P
Voss, G
Pathan, AA
Kester, KE
Brookes, R
Lee, E
Koutsoukos, M
Plebanski, M
Delchambre, M
Flanagan, KL
Carton, C
Slaoui, M
Van Hoecke, C
Ballou, WR
Hill, AVS
Cohen, J
Citation: A. Lalvani et al., Potent induction of focused Th1-type cellular and humoral immune responsesby RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine, J INFEC DIS, 180(5), 1999, pp. 1656-1664
Risultati:
1-9
|